In an article published on “eLife”, researchers at the University of Delaware and Indiana University found that the details of the unknown hepatitis B virus capsid, illuminating potentially new therapies for more than 250 million hepatitis B patients worldwide.   The capsids play the role of hepatitis B virus in injecting genetic material into host cells. They are a key target for the development of therapeutic drugs for hepatitis B….